Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS) - Eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction

被引:48
作者
Qi, S
Weng, ND
机构
[1] Covance Bioanalyt Serv LLC, Indianapolis, IN USA
[2] Covance Bioanalyt Chem, Madison, WI USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 830卷 / 01期
关键词
omeprazole; 5-OH omeprazole; HILIC-MS/MS; liquid/liquid extraction;
D O I
10.1016/j.jchromb.2005.10.042
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bioanalytical methods using liquid/liquid extraction (LLE) and liquid chromatography with electrospray tandem mass spectrometry (LC-MS/MS) are widely used. The organic extracts need to be evaporated and reconstituted, hampering further improvement of throughput and automation. In this study, we demonstrated a novel approach of eliminating these two steps in 96-well LLE by using hydrophilic interaction chromatography with MS/MS (HILIC-MS/MS) on silica column with high organic/low aqueous mobile phase. Omeprazole, its metabolite 5-OH omeprazole, and internal standard desoxyomeprazole, were extracted from 0.05 ml of human plasma using 0.5 ml of ethyl acetate in a 96-well plate. A portion (0.1 ml) of the ethyl acetate extract was diluted with 0.4 ml of acetonitrile and 10 mu l was injected onto a Betasil silica column (50 mm x 3.0 mm, 5 mu m) and detected by API 3000 and 4000 with (+) ESI. Mobile phase with linear gradient elution consists of acetonitrile, water, and formic acid (from 95:5:0.1 to 73.5:26.5:0.1 in 2 min). The flow rate was 1.5 ml/min with total run time of 2.75 min. The method was validated for a low limit of quantitation at 2.5 ng/ml for both analytes. The method was also validated for specificity, reproducibility, stability and recovery. Lack of adverse matrix effect and carry-over was also demonstrated. The inter-day precision and accuracy of the quality control samples at low, medium and high concentration levels were < 4.4% relative standard deviation (R.S.D.) and 4.1% relative error (R.E.) for omeprazole, and 4.5% R.S.D. and 5.6% R.E. for 5-OH omeprazole, respectively. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 33 条
[1]  
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO
[2]  
2-S
[3]   Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography [J].
Cheng, FC ;
Ho, YF ;
Hung, LC ;
Chen, CF ;
Tsai, TH .
JOURNAL OF CHROMATOGRAPHY A, 2002, 949 (1-2) :35-42
[4]   Detection of anti-ulcer drugs and their metabolites in horse urine by liquid chromatography - Mass spectrometry [J].
Chung, EW ;
Ho, ENM ;
Leung, DKK ;
Tang, FPW ;
Yiu, KCH ;
Wan, TSM .
CHROMATOGRAPHIA, 2004, 59 (Suppl 1) :S29-S38
[5]   Rapid pharmacokinetic screening for the selection of new drug discovery candidates using a generic isocratic liquid chromatography-atomospheric pressure ionization tandem mass spectrometry method [J].
Colwell, LF ;
Tamvakopoulos, CS ;
Wang, PR ;
Pivnichny, JV ;
Shih, TL .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 772 (01) :89-98
[6]   A rapid HPLC-DAD method for separation and determination of omeprazole extracted from human plasma [J].
Dubuc, MC ;
Hamel, C ;
Caubet, MS ;
Brazier, JL .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2001, 24 (08) :1161-1169
[7]   Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma [J].
Eerkes, A ;
Shou, WZ ;
Weng, ND .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :917-928
[8]   Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction [J].
García-Encina, G ;
Farrán, R ;
Puig, S ;
Martínez, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (02) :371-382
[9]   Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction [J].
González, HM ;
Romero, EM ;
Chavez, TD ;
Peregrina, AA ;
Quezada, V ;
Hoyo-Vadillo, C .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 780 (02) :459-465
[10]  
Grumbach ES, 2004, LC GC N AM, V22, P1010